DU PONT MERCK NAMES HORNER MANAGING DIRECTOR FOR U.K.
DU PONT MERCK NAMES HORNER MANAGING DIRECTOR FOR U.K. WILMINGTON, Del., Jan. 14 /PRNewswire/ -- The Du Pont Merck
Pharmaceutical Company has named Ann Horner managing director of its Du Pont Pharmaceuticals U.K. subsidiary.
Horner, a native of Washington, had previously been secretary to the Management Committee of the Wilmington-based drug company. Prior to that, she had been a group product manager. Du Pont Pharmaceuticals U.K. is headquartered in Letchworth, England. Horner and her family reside in Hertfordshire, England. Horner graduated from Washington College in 1980 with a bachelor's degree in biology and received a master's of business administration in 1985 from Wilmington College. Du Pont Merck, which began operations on Jan. 1, 1991, is an independent worldwide pharmaceutical company established by Du Pont (NYSE: DD) and Merck & Co., Inc. (NYSE: MRK). With R&D expenditures exceeding $230 million annually, it is a research-based company focused on therapeutics for cardiovascular and central nervous system diseases, oncology, inflammatory and viral diseases, and on radiopharmaceuticals. Du Pont Merck, headquartered in Wilmington, expects to report first-year sales of $700 million. /delval/ -0- 1/14/92 /CONTACT: Roger R. Morris of Du Pont Merck, 302-992-4747/ (DDD MRK) CO: Du Pont Merck Pharmaceutical Company ST: Delaware IN: MTC SU: PER
JS -- PH026 -- 9642 01/14/92 15:00 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Jan 14, 1992|
|Previous Article:||SOUTHERN NATURAL GAS COMPANY OFFERS $100 MILLION OF 7.85 PERCENT NOTES DUE JAN. 15, 2002|
|Next Article:||AT&T OFFERS GEORGIA RESIDENTS REDUCED LONG DISTANCE PRICES ON MARTIN LUTHER KING DAY|